A study of Tolvaptan to investigate the pharmacokinetics and diuretic effect

Trial Profile

A study of Tolvaptan to investigate the pharmacokinetics and diuretic effect

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2014

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Congenital heart defects; Heart failure
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 Mar 2014 Status changed from not yet recruiting to completed according to the results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
    • 31 Mar 2014 Results presented at the 63rd Annual Scientific Session of the American College of Cardiology.
    • 16 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top